Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Not stated	2024-12-27		NCT06751108

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Catholic Medical Center of Korea	2
Pusan National University Hospital	19
Seoul National University	14
Seoul National University Bundang Hospital	114
Seoul National University Hospital	277

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Seoul National University	Seoul	South Korea	4